Aprea Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Aprea Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2020 to Q3 2024.
  • Aprea Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 5.94M shares, a 59% increase year-over-year.
  • Aprea Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 3.62M shares, a 118% increase from 2022.
  • Aprea Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.66M shares, a 55.7% increase from 2021.
  • Aprea Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 1.06M shares, a 0.72% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 5.94M +2.2M +59% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 5.94M +2.21M +59.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 4.2M +938K +28.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 3.62M +1.96M +118% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-26
Q3 2023 3.74M +2M +116% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 3.73M +2.6M +229% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 3.26M +2.17M +198% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 1.66M +593K +55.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-26
Q3 2022 1.73M -19.5M -91.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 1.13M -20.1M -94.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 1.1M -20.1M -94.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 1.06M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-26
Q3 2021 21.2M +44.8K +0.21% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 21.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 21.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q3 2020 21.2M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.